FGFR2 and acute myeloblastic leukemia with maturation: In addition, AM harbors different oncogenic mutations, including BRAF, SMO, RAS, and FGFR2 mutations.7,8,42 AM with different mutation statuses might have distinct features, which need to be investigated in the future.